Question

Hand arthritis severity: ultrasound-pathology vs functional capacity. In older adults (≥70y) with symptomatic hand arthritis (OA and/or RA), how strongly do ultrasound (US) measures of synovitis and osteophyte burden relate to functional capacity, and which US features explain unique variance in function beyond pain, demographics, and comorbidities?

Answer (protocol-grade plan + expected benchmarks)

1) What to measure (domains & instruments)

Domain	Instrument / Protocol	Metric	Notes
US synovitis (inflammation)	Semi‑quantitative grayscale (GS 0–3) and power Doppler (PD 0–3) at MCP2–5, PIP2–5, DIP2–5, 1st CMC (bilateral)	GS_sum, PD_sum (joint‑level scores summed)	Readers blinded; consensus atlas; per‑joint PD≥1 indicates active synovitis
US osteophytes & erosions (structure)	Osteophyte grade 0–3 at PIP/DIP/1st CMC; erosions 0/1 at MCP/PIP (RA‑salient)	Osteophyte_sum; Erosion_count	Static images archived for reliability
Function (PRO)	AUSCAN Function (hand OA) and/or QuickDASH (upper limb disability)	0–100 (higher = worse)	Choose primary based on case‑mix; both collected if feasible
Dexterity / performance	Nine‑Hole Peg Test (9HPT) or Purdue Pegboard	Time (s) or pins placed	Best of two trials, dominant and non‑dominant hands
Strength	Grip dynamometry; key pinch & tip pinch	kg (best of 3); kg	Standard elbow 90°, wrist neutral position
Pain severity	Pain NRS (0–10); AUSCAN Pain	0–10; 0–100	Anchor for mediation analyses
Confounders	Age, sex, BMI, hand dominance, RA vs OA, CRP/ESR, neuropathy screen (monofilament), CTS screen (Phalen/Tinel), sarcopenia (SARC‑F + grip)	—	Pre‑specified covariates

2) Study design

Design: Cross‑sectional primary analysis + 6‑month retest subset (n≈60) for reliability and minimal detectable change (MDC).
Population: n = 220 community/clinic adults ≥70 years with symptomatic hand OA and/or RA; exclude recent intra‑articular steroid (<4 weeks) or surgery (<6 months).
Imaging: High‑frequency linear probe (≥12 MHz); standard dorsal/volar scans; machine settings locked across visits.

3) Composite ultrasound severity scores (to evaluate)

US‑Inflammation Index (US‑II): PD_sum + 0.5·GS_sum (0–>max); emphasizes active synovitis.
US‑Structural Index (US‑SI): Osteophyte_sum + 2·Erosion_count; emphasizes chronic damage.
US‑Hand Severity Score (US‑HSS): z‑score composite of US‑II and US‑SI (rescaled 0–100).

4) Statistical analysis plan (SAP)

Primary model: Multivariable linear regression with functional capacity as outcome (AUSCAN‑Function primary). Key predictors: US‑II and US‑SI entered together.
Adjust for: Age, sex, BMI, RA vs OA, pain NRS, grip strength, neuropathy/CTS screens, hand dominance.
Report: Standardized β, partial R² for US‑II and US‑SI, overall adjusted R². Check multicollinearity (VIF<3).
Secondary: Models using 9HPT (time), QuickDASH, and grip as outcomes; logistic regression for severe disability (AUSCAN‑Function ≥75th percentile).
Mediation: Does pain mediate the US‑II → function pathway? Use bootstrapped indirect effect (5,000 resamples).
Effect modification: Test interaction US‑II×RA (RA vs OA) and US‑SI×sex; stratify if p<0.10.
Reliability: Intra/inter‑reader ICC(2,1) for GS/PD/osteophytes; compute MDC₉₅ = 1.96·√2·SEM.

5) Power & sample size (sketch)

Detect partial R² = 0.07 (≈ standardized β ≈ 0.27) for US‑II after covariates with α=0.05, power=0.90, ~10 predictors → N≈200 adequate.
Reliability target ICC ≥0.80 requires ~40–60 joint‑level repeats per reader.

6) Benchmarks to claim success (pre‑specified)

Property	Threshold
Construct validity (US‑II vs inflammation)	US‑II correlates with CRP/ESR (r ≥ 0.30)
Criterion validity (function)	Adjusted model R² ≥ 0.40 with US terms adding ≥ 0.07 partial R²
Relative importance	US‑II explains more variance in function than US‑SI (∆partial R² ≥ 0.03)
Reliability	ICC ≥ 0.85 for PD_sum; ICC ≥ 0.80 for GS_sum and osteophytes
MDC	MDC₉₅ for PD_sum small enough to detect 6‑month change in ≥30% of participants

7) Expected findings & interpretation

Inflammation dominates function: US‑II (PD‑weighted) shows moderate, independent association with disability (standardized β ≈ 0.30), exceeding the contribution of structural damage (US‑SI).
Dexterity is sensitive: 9HPT times worsen by ~4–6% per SD increase in US‑II after adjustment.
Strength linkage: Grip declines ~1.5–2.0 kg per SD increase in US‑SI, partially independent of pain.
Mediation: 30–50% of US‑II’s effect on function operates through pain intensity; a residual direct effect indicates stiffness/swelling‑driven mechanics.
Clinical translation: High US‑II identifies candidates for anti‑inflammatory strategies (local/systemic); high US‑SI with low US‑II suggests splinting/hand therapy and joint‑protection emphasis.

8) Practical cut‑points (provisional; to validate)

Mild: US‑II < 10 and US‑SI < 20 — self‑management, ROM/strengthening.
Moderate: US‑II 10–24 or US‑SI 20–39 — structured hand therapy, splints (e.g., 1st CMC), analgesic optimization.
Severe: US‑II ≥ 25 or US‑SI ≥ 40 — consider injections, RA escalation, surgical consult for 1st CMC or advanced erosive disease.

9) Pseudocode (analysis skeleton)

# y: AUSCAN_Function (0–100, higher = worse)
# x1: US_II (PD_sum + 0.5 * GS_sum), x2: US_SI (Osteophyte_sum + 2 * Erosion_count)
# covariates: age, sex, BMI, RA, pain_NRS, grip, neuropathy, CTS, dominance

model <- lm(y ~ x1 + x2 + age + sex + BMI + RA + pain_NRS + grip + neuropathy + CTS + dominance, data=hand)
summary(model)            # standardized betas & adjusted R²
anova(base_model, model)  # partial R² of US terms
mediation <- mediate(model_USII_to_pain, model_pain_to_function, boot=5000)

Abbreviations — AUSCAN: Australian/Canadian Hand Osteoarthritis Index; QuickDASH: Disabilities of the Arm, Shoulder and Hand (short form); MCP/PIP/DIP: metacarpophalangeal/proximal/distal interphalangeal joints; 1st CMC: first carpometacarpal joint; GS: grayscale; PD: power Doppler; ICC: intraclass correlation coefficient; MDC: minimal detectable change; ROM: range of motion; CTS: carpal tunnel syndrome.

Artificial Intelligence Doctor